Integrative Analysis of Large-cell Lung Cancer
Recruiting
Observational Study
Lung Cancer
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 75
- Sex
- Any
- Study type
- Observational
- Participants needed
- 1,000 (estimated)
- Sponsor
- Shanghai 10th People's Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Integrative analysis of LCLC
Trial Locations
Sorted by distance from Colorado
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age ≤ 75 years with histologically proven LCLC
* No severe major organ dysfunction
* World Health Organization (WHO) performance status of 0 or 1
* No prior cancer chemotherapy
Exclusion Criteria:
* Age ≥ 76
* Severe major organ dysfunction
* WHO performance status of \>1
* …
Contacts